Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO.
| Revenue (Most Recent Fiscal Year) | $185.07M |
| Net Income (Most Recent Fiscal Year) | $-17.70M |
| PE Ratio (Current Year Earnings Estimate) | 322.00 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.18 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.87 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -14.86% |
| Net Margin (Trailing 12 Months) | -9.99% |
| Return on Equity (Trailing 12 Months) | -16.91% |
| Return on Assets (Trailing 12 Months) | -11.43% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.26 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.28 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.45 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.86 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.20 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.34 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.11 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 135.13M |
| Free Float | 135.01M |
| Market Capitalization | $217.56M |
| Average Volume (Last 20 Days) | 1.29M |
| Beta (Past 60 Months) | 1.52 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.09% |
| Percentage Held By Institutions (Latest 13F Reports) | 34.63% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |